“Adaptive Licensing and Conditional Approval: A Perspective on Evidence Owed After Market Entry”. Translational Medicine & Therapeutics Journal, vol. 2, no. 2, Nov. 2023, pp. 92-100, https://doi.org/10.5281/zenodo.22649112.